![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 8
Zeitschriftenartikel
Hoffmann, Gordon Victor 
ORCID: https://orcid.org/0009-0007-3167-2124; Gottschlich, Adrian ORCID: https://orcid.org/0000-0002-2898-4182; Subklewe, Marion ORCID: https://orcid.org/0000-0001-9154-9469 und Kobold, Sebastian ORCID: https://orcid.org/0000-0002-5612-4673
(Juni 2025):
Novel approaches to CAR T cell target identification in acute myeloid leukemia.
In: Current Opinion in Pharmacology, Bd. 82, 102524
[PDF, 725kB]
ORCID: https://orcid.org/0009-0007-3167-2124; Gottschlich, Adrian ORCID: https://orcid.org/0000-0002-2898-4182; Subklewe, Marion ORCID: https://orcid.org/0000-0001-9154-9469 und Kobold, Sebastian ORCID: https://orcid.org/0000-0002-5612-4673
(Juni 2025):
Novel approaches to CAR T cell target identification in acute myeloid leukemia.
In: Current Opinion in Pharmacology, Bd. 82, 102524
[PDF, 725kB]
Schmitt, Christina ORCID: https://orcid.org/0000-0001-9592-2347; Müller, Katharina J.; Tiedt, Steffen; Kramer, Nora; Manger, Isabel; Knauss, Samuel; Müller‐Jensen, Leonie; Huehnchen, Petra; Boehmerle, Wolfgang; Schöberl, Florian; Heinzerling, Lucie ORCID: https://orcid.org/0000-0001-5718-3643 und Baumgarten, Louisa von ORCID: https://orcid.org/0000-0002-6634-0927
(2025):
Increased serum NfL and GFAP levels indicate different subtypes of neurologic immune‐related adverse events during treatment with immune checkpoint inhibitors.
In: International Journal of Cancer, Bd. 156, Nr. 10: S. 1961-1971
[PDF, 1MB]
ORCID: https://orcid.org/0000-0001-9592-2347; Müller, Katharina J.; Tiedt, Steffen; Kramer, Nora; Manger, Isabel; Knauss, Samuel; Müller‐Jensen, Leonie; Huehnchen, Petra; Boehmerle, Wolfgang; Schöberl, Florian; Heinzerling, Lucie ORCID: https://orcid.org/0000-0001-5718-3643 und Baumgarten, Louisa von ORCID: https://orcid.org/0000-0002-6634-0927
(2025):
Increased serum NfL and GFAP levels indicate different subtypes of neurologic immune‐related adverse events during treatment with immune checkpoint inhibitors.
In: International Journal of Cancer, Bd. 156, Nr. 10: S. 1961-1971
[PDF, 1MB]
Kazerani, Maryam ORCID: https://orcid.org/0000-0002-5803-4807; Marcinek, Anetta; Philipp, Nora ORCID: https://orcid.org/0000-0002-3918-7795; Brauchle, Bettina; Taylor, Jonathan Jonas; Moreno, Helena Domínguez; Terrasi, Andrea; Tast, Benjamin; Rohrbacher, Lisa; Wang, Yingshuai; Warm, Maximilian; Emhardt, Alica-Joana; Magno, Giulia; Spiekermann, Karsten ORCID: https://orcid.org/0000-0002-5139-4957; Herold, Tobias ORCID: https://orcid.org/0000-0002-9615-9432; Straub, Tobias ORCID: https://orcid.org/0000-0002-0547-0453; Theurich, Sebastian ORCID: https://orcid.org/0000-0001-5706-8258; Schotta, Gunnar ORCID: https://orcid.org/0000-0003-4940-6135; Kischel, Roman; Bücklein, Veit L. ORCID: https://orcid.org/0000-0001-7391-7280 und Subklewe, Marion ORCID: https://orcid.org/0000-0001-9154-9469
(22. August 2024):
Evolution of T-cell fitness through AML progression: enhanced bispecific T-cell engager-mediated function of bone marrow T cells at remission compared to initial diagnosis and relapse.
In: Leukemia, Bd. 38: S. 2270-2275
[PDF, 2MB]
ORCID: https://orcid.org/0000-0002-5803-4807; Marcinek, Anetta; Philipp, Nora ORCID: https://orcid.org/0000-0002-3918-7795; Brauchle, Bettina; Taylor, Jonathan Jonas; Moreno, Helena Domínguez; Terrasi, Andrea; Tast, Benjamin; Rohrbacher, Lisa; Wang, Yingshuai; Warm, Maximilian; Emhardt, Alica-Joana; Magno, Giulia; Spiekermann, Karsten ORCID: https://orcid.org/0000-0002-5139-4957; Herold, Tobias ORCID: https://orcid.org/0000-0002-9615-9432; Straub, Tobias ORCID: https://orcid.org/0000-0002-0547-0453; Theurich, Sebastian ORCID: https://orcid.org/0000-0001-5706-8258; Schotta, Gunnar ORCID: https://orcid.org/0000-0003-4940-6135; Kischel, Roman; Bücklein, Veit L. ORCID: https://orcid.org/0000-0001-7391-7280 und Subklewe, Marion ORCID: https://orcid.org/0000-0001-9154-9469
(22. August 2024):
Evolution of T-cell fitness through AML progression: enhanced bispecific T-cell engager-mediated function of bone marrow T cells at remission compared to initial diagnosis and relapse.
In: Leukemia, Bd. 38: S. 2270-2275
[PDF, 2MB]
Dalloul, Iman; Strzalkowski, Thaddaeus Jan Clemens; Bergwelt-Baildon, Michael von; Nuessler, Volkmar; Zielinski, Christoph und Kobold, Sebastian
(2022):
9th Immunotherapy of Cancer conference (ITOC): A meeting report.
In: Human Vaccines & Immunotherapeutics, Bd. 18, Nr. 7
[PDF, 631kB]
Monteagudo-Mesas, Pablo; Broenner, Cornelia; Kohvaei, Parastou; Amedi, Haris; Canzar, Stefan und Halic, Mario
(2022):
Ccr4-Not complex reduces transcription efficiency in heterochromatin.
In: Nucleic Acids Research, Bd. 50, Nr. 10: S. 5565-5576
Ringeling, Francisca Rojas; Chakraborty, Shounak; Vissers, Caroline; Reiman, Derek; Patel, Akshay M.; Lee, Ki-Heon; Hong, Ari; Park, Chan-Woo; Reska, Tim; Gagneur, Julien; Chang, Hyeshik; Spletter, Maria L.; Yoon, Ki-Jun; Ming, Guo-li; Song, Hongjun und Canzar, Stefan
(2022):
Partitioning RNAs by length improves transcriptome reconstruction from short-read RNA-seq data.
In: Nature Biotechnology, Bd. 40, Nr. 5: S. 741-750
Dorman, Klara; Heinemann, Volker; Kobold, Sebastian; Bergwelt-Baildon, Michael von und Boeck, Stefan
(2022):
Novel systemic treatment approaches for metastatic pancreatic cancer.
In: Expert Opinion on Investigational Drugs, Bd. 31, Nr. 3: S. 249-262
Markl, Florian; Huynh, Duc; Endres, Stefan und Kobold, Sebastian
(2022):
Utilizing chemokines in cancer immunotherapy.
In: Trends in Cancer, Bd. 8, Nr. 8: S. 670-682